Arbor Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2010
Total raised
- $17M
Investors
- 3
About Arbor Pharmaceuticals
Founded in 2006 and headquartered in Atlanta, US, Arbor Pharmaceuticals develops specialty medications with a commitment to enhancing patient care. The company was acquired in August 2021 by Azurity Pharmaceuticals, aligning with a strategy to expand the range of patient-centric products. Ed Schutter serves as the CEO of Arbor Pharmaceuticals.Arbor Pharmaceuticals offers a diverse portfolio of over 50 medications across 10 dosage forms and key therapeutic areas, which include Allergy, Cardiovascular, Central Nervous System, Endocrinology, Gastrointestinal, Hematology, Immunology, Oncology, and Respiratory health. Among its notable products are BRYNOVIN™ (sitagliptin), used for type 2 diabetes management, and XIFYRM™ (meloxicam injection), a non-steroidal anti-inflammatory drug for moderate-to-severe pain.Arbor Pharmaceuticals generates revenue primarily through direct sales of its branded products to healthcare providers, hospitals, and specialty pharmacies. Utilizing a B2B approach, the company partners with distributors and healthcare networks to enhance product accessibility.Following the acquisition by Azurity Pharmaceuticals in August 2021, Arbor Pharmaceuticals aims to bolster its product line and market reach. The company plans to introduce new products designed to address unmet medical needs, although specific details on release dates remain undisclosed. Expanding into additional markets is also a priority, with targeted regions yet to be specified.30 mn will support these initiatives, aligning with the overarching vision of developing high-value products that cater to patient requirements.
Who invested in Arbor Pharmaceuticals
3 investors across 1 round
See all investors in Arbor Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 5, 2010
Amount
$17M
Investors
Questions about Arbor Pharmaceuticals
Who invested in Arbor Pharmaceuticals?
Arbor Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arbor Pharmaceuticals raised?
Arbor Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Arbor Pharmaceuticals last raise money?
Arbor Pharmaceuticals's most recent round on record is a Series B, in Nov 2010.
What does Arbor Pharmaceuticals do?
Founded in 2006 and headquartered in Atlanta, US, Arbor Pharmaceuticals develops specialty medications with a commitment to enhancing patient care.
Where is Arbor Pharmaceuticals headquartered?
Arbor Pharmaceuticals is headquartered in Atlanta, US.
Which VCs invest in companies like Arbor Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arbor Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Arbor Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.